AstraZeneca (LON:AZN) Stock Price Crosses Above 200-Day Moving Average of $10,438.91

AstraZeneca PLC (LON:AZN - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of £104.39 ($131.92) and traded as high as £107.80 ($136.23). AstraZeneca shares last traded at £106.78 ($134.94), with a volume of 1,276,799 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Berenberg Bank reiterated a "buy" rating on shares of AstraZeneca in a research report on Wednesday, March 13th. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of AstraZeneca in a research note on Tuesday, March 12th. Jefferies Financial Group restated a "hold" rating and issued a £110 ($139.01) price target on shares of AstraZeneca in a research note on Friday, February 16th. Shore Capital reiterated a "buy" rating on shares of AstraZeneca in a report on Thursday, February 8th. Finally, BMO Capital Markets restated an "outperform" rating on shares of AstraZeneca in a research note on Monday, February 12th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat, AstraZeneca has a consensus rating of "Moderate Buy" and a consensus target price of £117.13 ($148.02).

AstraZeneca Stock Down 0.6 %

The firm has a market cap of £165.51 billion, a P/E ratio of 3,547.51, a price-to-earnings-growth ratio of 0.86 and a beta of 0.17. The firm's 50-day moving average price is £102.71 and its 200 day moving average price is £104.41. The company has a quick ratio of 0.59, a current ratio of 0.82 and a debt-to-equity ratio of 75.70.

AstraZeneca Increases Dividend

The firm also recently declared a dividend, which was paid on Monday, March 25th. Stockholders of record on Thursday, February 22nd were issued a dividend of GBX 156 ($1.97) per share. This represents a dividend yield of 1.49%. The ex-dividend date was Thursday, February 22nd. This is a boost from AstraZeneca's previous dividend of $71.80. AstraZeneca's payout ratio is 7,574.75%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.